Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
1. Genetic screening to avoid adverse drug reactions from medication use and approach patients' better outcomes: A lesson learn from the report of the Queen Savang Vadhana Memorial Hospital
- Tunwongsa K. , et al.
2. Pegylated interferon and ribavirin gone but not forgotten in the era of direct-acting antivirals
- Pluta M. , et al.
3. Association of mutations in the ns5a-pkrbd region and ifnl4 geno-types with hepatitis c interferon responsiveness and its functional and structural analysis
- Hashempour T. , et al.
4. Association of IL28 B and IL10 Polymorphism with HCV Infection and Direct Antiviral Treatment
- Junaid K. , et al.
5. Distribution of IL28B rs12979860 and rs8099917 genotypes in patients with chronic hepatitis C virus infection in Tianjin, China
- Qiao K. , et al.
6. Distribution of polymorphisms rs12979860, rs8099917 and rs12980275 IL28B in patients with chronic hepatitis C
- Wysocka-Leszczyńska J. , et al.
7. Role of serum level and genetic variation of IL-28B in interferon responsiveness and advanced liver disease in chronic hepatitis C patients
- Alborzi A. , et al.
8. IL28B rs12980275 and HLA rs4273729 genotypes as a powerful predictor factor for rapid, early, and sustained virologic response in patients with chronic hepatitis C
- Sedighimehr P. , et al.
9. Analysis of a relationship between stages of liver fibrosis and virological, immunological and certain genetic parameters in patients with chronic hepatitis C
- Nikolaeva L.I. , et al.
10. Polymorphisms at IL28B gene as predictors of viral relapse in genotype 4 Egyptian hepatitis C patients
- Esmail M.A. , et al.
11. The influence of anti-HBc status on the sustained virological response rate in HCV-infected patients treated with pegylated interferon alfa 2 and ribavirin
- Szymanek-Pasternak A. , et al.
12. Single nucleotide polymorphisms near IL28B gene and response to treatment of chronic hepatitis C in hemodialysis patients
- Dzekova-Vidimliski P. , et al.
13. Interferon-λpolymorphisms and response to pegylated interferon in Iranian hepatitis C patients
- Haj-sheykholeslami A. , et al.
14. The impact of IL28B genotype and liver fibrosis on the hepatic expression of IP10, IFI27, ISG15, and MX1 and their association with treatment outcomes in patients with chronic hepatitis C
- Domagalski K. , et al.
15. Genetic predictors of the response to the treatment of hepatitis C virus infection
- Dzekova-Vidimliski P. , et al.
16. IL28B polymorphism (rs12979860) associated with clearance of HCV infection in Poland: Systematic review of its prevalence in chronic hepatitis C patients and general population frequency
- Kaczor M.P. , et al.
17. Are statins a viable option for the treatment of infections with the hepatitis C virus?
- Verpaalen B. , et al.